You must be at least 21 to visit this site. Please enter your DOB to confirm your age.
Current research listings
Review the available presentation, strength and price before adding a research product to your order.
For laboratory research purposes only
Research seriesIndividual compound
An amylin analogue studied for how the brain and digestive system communicate signals of fullness. Research commonly examines appetite regulation, gastric emptying and energy balance. Available strengths: 10mg · 20mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A GLP-1 receptor agonist used in research into blood-sugar signalling, appetite and energy balance. It helps scientists examine how GLP-1 pathways influence insulin release and feelings of fullness. Available strengths: 5mg · 10mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A dual GIP and GLP-1 receptor agonist studied for its effects on metabolic signalling. Researchers use it to explore glucose control, appetite regulation and the interaction between two incretin pathways. Available strengths: 20mg · 40mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A triple-receptor research compound acting on GIP, GLP-1 and glucagon pathways. It is studied to understand how these combined signals affect appetite, glucose handling and energy expenditure. Available strengths: 10mg · 20mg · 40mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A peptide produced from mitochondrial DNA and studied as a signal between cells and their energy-producing machinery. Research focuses on cellular energy use, metabolic flexibility and responses to physical stress. Available strengths: 10mg · 20mg · 40mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A small-molecule NNMT inhibitor studied in metabolic and cellular-energy research. Scientists investigate how reducing NNMT activity may change energy use and fat-cell metabolism. Available strength: 100mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A research compound that activates AMPK, often described as a cellular fuel sensor. It is used to study energy regulation, glucose uptake and how cells respond when energy is limited. Available strength: 50mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A mitochondria-targeting peptide studied for its interaction with cardiolipin inside the mitochondrial membrane. Research explores mitochondrial efficiency, oxidative stress and cellular protection. Available strength: 10mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
An experimental activator of oestrogen-related receptors involved in energy metabolism. Early laboratory research examines mitochondrial activity, endurance-related pathways and fat oxidation. Available strength: 1.5mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A synthetic peptide studied in laboratory models of tissue repair and inflammation. Research looks at blood-vessel signalling and the response of tendons, muscle and digestive tissues to injury. Available strength: 10mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A research form associated with thymosin beta-4, a protein involved in cell movement and tissue organisation. Studies examine repair signalling, new blood-vessel formation and inflammatory responses. Available strength: 10mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A short fragment of alpha-MSH studied for anti-inflammatory and antimicrobial signalling. Researchers often examine its effects in skin, intestinal and immune-cell models. Available strength: 10mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A peptide derived from erythropoietin that is designed to activate tissue-protective signalling without stimulating red-blood-cell production. Research focuses on inflammation, nerve health and tissue repair. Available strength: 16mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A naturally occurring antimicrobial peptide that forms part of the body's innate immune response. Laboratory studies investigate microbial defence, immune signalling and wound-repair processes. Available strength: 5mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A short-acting GHRH analogue studied for how it signals the pituitary gland to release growth hormone. It is used to explore pulsatile growth-hormone and IGF-1 pathways. Available strength: 10mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A longer-acting GHRH analogue designed to remain in circulation for extended research observation. Studies examine sustained growth-hormone and IGF-1 signalling. Available strength: 10mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A growth-hormone secretagogue that activates the ghrelin receptor. Researchers use it to study growth-hormone release, appetite signalling and pituitary responses. Available strength: 10mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A ghrelin-receptor agonist studied for its effect on growth-hormone release and appetite pathways. It helps researchers compare endocrine responses among growth-hormone secretagogues. Available strength: 10mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A selective ghrelin-receptor agonist studied for growth-hormone release with limited activity at some other pituitary pathways. Research examines the timing and selectivity of endocrine signalling. Available strength: 10mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A shortened analogue of natural growth-hormone-releasing hormone. It is studied to understand pituitary growth-hormone pulses and downstream IGF-1 signalling. Available strength: 10mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A stabilised GHRH analogue studied for its ability to stimulate the body's growth-hormone pathway. Research considers pituitary signalling, IGF-1 and changes in lipid metabolism. Available strength: 10mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A potent ghrelin-receptor agonist and growth-hormone secretagogue. Laboratory work examines endocrine release patterns and possible signalling in cardiac and metabolic tissues. Available strength: 5mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A fragment from the end of human growth hormone studied separately from the full hormone. Research focuses mainly on fat-cell signalling and lipid breakdown pathways. Available strength: 10mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A long-acting laboratory analogue of insulin-like growth factor 1. It is used to study cell growth, protein synthesis, glucose transport and IGF-receptor signalling. Available strength: 1mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A 191-amino-acid form matching human growth hormone, used as a reference in endocrine research. Studies examine growth, metabolism and signalling through the growth-hormone receptor. Available strength: 30 IU. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A modified fragment of human growth hormone developed for research into fat metabolism without the full hormone's growth effects. Studies examine lipolysis and fat-cell signalling. Available strength: 10mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
An experimental peptidomimetic designed to target blood vessels supplying white fat tissue in preclinical models. Research investigates targeted vascular and fat-tissue responses. Available strength: 10mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A short synthetic peptide inspired by pineal-gland research. Laboratory studies explore cellular ageing, telomere biology, circadian signalling and oxidative stress. Available strength: 20mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A terminally modified form of Epitalon designed for stability in research settings. It is studied in the same broad areas of cellular ageing, stress responses and circadian biology. Available strength: 20mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
An experimental peptide designed to disrupt an interaction involving the FOXO4 protein in senescent cells. Preclinical research explores cellular ageing and the selective removal of damaged cells. Available strength: 5mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A naturally occurring copper-binding peptide involved in cell communication. Research examines collagen production, skin remodelling, wound repair and antioxidant responses. Available strength: 100mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A mitochondria-derived peptide studied for cell-survival signalling. Researchers investigate its role in oxidative stress, metabolism, ageing and protection of nerve cells. Available strength: 10mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A coenzyme essential to energy production and many repair enzymes. Laboratory research uses NAD+ to examine mitochondrial function, redox balance, DNA repair and cellular ageing. Available strengths: 500mg · 1000mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A naturally occurring building block used by cells to make NAD+. Research focuses on NAD+ metabolism, energy production and how these pathways change with age. Available strength: 1000mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A vitamin B3-related precursor that cells can convert into NAD+. It is studied for its effects on cellular energy, mitochondrial function and NAD+ availability. Available strength: 1000mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A major antioxidant made naturally by cells. Researchers study how it supports redox balance, detoxification reactions and protection from oxidative stress. Available strength: 1000mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A plant-derived polyphenol studied for its effects on inflammatory, antioxidant and cell-signalling pathways. Laboratory work also examines its stability and bioavailability. Available strength: 150mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
An experimental peptide designed to interact with HDM2 on certain abnormal cells. It remains a preclinical research compound studied in cell models of targeted membrane disruption. Available strength: 5mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A thymic peptide studied for its role in coordinating innate and adaptive immune responses. Research examines T-cell activity, dendritic-cell signalling and immune regulation. Available strength: 5mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A thymus-derived peptide preparation studied in bioregulation and immune-ageing research. Investigations focus on thymic function and immune-cell signalling. Available strength: 20mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A soluble activin receptor research protein designed to bind myostatin-related ligands. It is studied to understand regulation of muscle growth and the activin signalling pathway. Available strength: 1mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A synthetic peptide related to the immune peptide tuftsin. Research examines stress responses, learning, memory and signalling involving GABA and other neurotransmitter systems. Available strength: 10mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A synthetic fragment related to ACTH that lacks the hormone's adrenal effects. Laboratory studies explore neuroprotective signalling, attention, learning and responses to reduced blood flow. Available strength: 10mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A modified Semax analogue designed for greater stability in experimental settings. Research explores neuroprotective, cognitive and stress-response pathways. Available strength: 30mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A modified Selank analogue designed for greater stability. It is studied in models of stress, memory and neurotransmitter regulation. Available strength: 30mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A naturally identified peptide studied for possible links with sleep and neuroendocrine regulation. Findings are mixed, so it remains mainly a tool for exploratory sleep and stress research. Available strength: 10mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
An experimental peptide derived from the prosaposin protein. Early research examines neurogenesis, mood-related behaviour and signalling that supports nerve cells. Available strength: 10mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
An experimental peptide derived from a region of ciliary neurotrophic factor. Preclinical work studies neurogenesis, learning and the survival of developing nerve cells. Available strength: 10mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A natural signalling peptide found in the nervous, digestive and immune systems. Research examines blood-vessel relaxation, airway signalling, inflammation and circadian regulation. Available strength: 10mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
An experimental peptide analogue investigated in neurological research. Available evidence is limited, so its mechanisms and effects remain subjects of early laboratory study. Available strength: 10mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A melanocortin-receptor agonist studied for central nervous system pathways involved in sexual response. Unlike compounds acting directly on blood vessels, it is used to examine brain-led signalling. Available strength: 10mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A synthetic analogue of alpha-MSH that activates several melanocortin receptors. Research examines pigment production, appetite and sexual-response signalling. Available strength: 10mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A synthetic alpha-MSH analogue studied mainly for activation of the MC1 receptor in pigment-producing cells. Research explores melanin formation and cellular responses to ultraviolet exposure. Available strength: 10mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A laboratory form of the natural peptide hormone oxytocin. Research examines social and stress-related signalling as well as smooth-muscle and reproductive physiology. Available strength: 10mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
Human chorionic gonadotropin is a hormone that activates the same receptor as luteinising hormone. It is used in research into reproductive endocrinology and gonadal steroid signalling. Available strength: 5000 IU. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A short active fragment of kisspeptin that stimulates GnRH signalling. Researchers use it to study the hormonal pathway controlling puberty, fertility and reproductive hormone release. Available strength: 10mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A short thymic bioregulator studied for gene-expression and immune-cell signalling. Evidence is primarily preclinical and focuses on thymic and immune ageing models. Available strength: 20mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A peptide bioregulator studied in models of blood-vessel tissue and endothelial function. Research explores tissue-specific gene signalling and vascular ageing. Available strength: 20mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A peptide bioregulator investigated in bladder-tissue models. Research is early-stage and examines tissue-specific regulation and cellular maintenance. Available strength: 20mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A peptide bioregulator studied in testicular-tissue and reproductive-ageing models. Research examines tissue-specific gene expression and endocrine function. Available strength: 20mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A peptide bioregulator investigated in liver-cell models. Studies focus on tissue-specific regulation, metabolic function and cellular repair responses. Available strength: 20mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A peptide bioregulator studied in cartilage and connective-tissue models. Research examines cell maintenance, extracellular matrix signalling and age-related change. Available strength: 20mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A peptide bioregulator investigated in ovarian-tissue and reproductive-ageing research. Evidence remains preclinical and focuses on tissue-specific signalling. Available strength: 20mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A peptide bioregulator studied in prostate-tissue models. Research explores tissue-specific gene regulation and cellular maintenance. Available strength: 20mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A peptide bioregulator investigated in brain and cortical-tissue models. Early research examines nerve-cell regulation, stress responses and ageing. Available strength: 20mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A peptide bioregulator studied in pancreatic-tissue models. Research explores cell regulation and pathways involved in digestive and metabolic function. Available strength: 20mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A peptide bioregulator investigated in lung and bronchial-tissue models. Research focuses on tissue-specific gene expression and cellular repair. Available strength: 20mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A short thymic dipeptide studied for immune regulation and T-cell development. Research examines how thymic signals influence immune-cell activity. Available strength: 20mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A peptide bioregulator studied in bronchial and respiratory-tissue models. Early work examines tissue maintenance and gene-regulatory effects. Available strength: 20mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A peptide bioregulator investigated in lens and eye-tissue models. Research considers tissue-specific protein regulation and age-related cellular change. Available strength: 20mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A peptide bioregulator studied in heart-muscle cell models. Research examines tissue-specific signalling, cellular stress and myocardial ageing. Available strength: 20mg. For laboratory research only; not for human consumption.
Research seriesIndividual compound
A short peptide bioregulator investigated in neurological and pineal research. Studies explore memory, oxidative stress and age-related nerve-cell changes. Available strength: 20mg. For laboratory research only; not for human consumption.
Research seriesCompound blend
A combined research formulation containing BPC-157, TB-500. It allows researchers to examine these compounds together within one controlled experimental preparation and compare their complementary signalling pathways. Available strength: 10mg / 10mg. For laboratory research only; not for human consumption.
Research seriesCompound blend
A combined research formulation containing BPC-157, TB-500, GHK-Cu. It allows researchers to examine these compounds together within one controlled experimental preparation and compare their complementary signalling pathways. Available strength: 10mg / 10mg / 50mg. For laboratory research only; not for human consumption.
Research seriesCompound blend
A combined research formulation containing BPC-157, TB-500, KPV, GHK-Cu. It allows researchers to examine these compounds together within one controlled experimental preparation and compare their complementary signalling pathways. Available strength: 10mg / 10mg / 10mg / 50mg. For laboratory research only; not for human consumption.
Research seriesCompound blend
A combined research formulation containing CJC-1295 (No DAC), GHRP-2. It allows researchers to examine these compounds together within one controlled experimental preparation and compare their complementary signalling pathways. Available strength: 5mg / 5mg. For laboratory research only; not for human consumption.
Research seriesCompound blend
A combined research formulation containing CJC-1295 (No DAC), GHRP-6. It allows researchers to examine these compounds together within one controlled experimental preparation and compare their complementary signalling pathways. Available strength: 5mg / 5mg. For laboratory research only; not for human consumption.
Research seriesCompound blend
A combined research formulation containing CJC-1295 (With DAC), Ipamorelin. It allows researchers to examine these compounds together within one controlled experimental preparation and compare their complementary signalling pathways. Available strength: 5mg / 5mg. For laboratory research only; not for human consumption.
Research seriesCompound blend
A combined research formulation containing CJC-1295 (No DAC), Ipamorelin. It allows researchers to examine these compounds together within one controlled experimental preparation and compare their complementary signalling pathways. Available strength: 5mg / 5mg. For laboratory research only; not for human consumption.
Research seriesCompound blend
A combined research formulation containing CJC-1295 (No DAC), GHRP-2, Ipamorelin. It allows researchers to examine these compounds together within one controlled experimental preparation and compare their complementary signalling pathways. Available strength: 3mg / 3mg / 3mg. For laboratory research only; not for human consumption.
Research seriesCompound blend
A combined research formulation containing Tesamorelin, CJC-1295 (No DAC), Ipamorelin. It allows researchers to examine these compounds together within one controlled experimental preparation and compare their complementary signalling pathways. Available strength: 6mg / 3mg / 3mg. For laboratory research only; not for human consumption.
Research seriesCompound blend
A combined research formulation containing Sermorelin, Ipamorelin. It allows researchers to examine these compounds together within one controlled experimental preparation and compare their complementary signalling pathways. Available strength: 5mg / 5mg. For laboratory research only; not for human consumption.
Research seriesCompound blend
A combined research formulation containing Sermorelin, GHRP-2. It allows researchers to examine these compounds together within one controlled experimental preparation and compare their complementary signalling pathways. Available strength: 5mg / 5mg. For laboratory research only; not for human consumption.
Research seriesCompound blend
A combined research formulation containing Sermorelin, GHRP-6. It allows researchers to examine these compounds together within one controlled experimental preparation and compare their complementary signalling pathways. Available strength: 5mg / 5mg. For laboratory research only; not for human consumption.
Research seriesCompound blend
A combined research formulation containing Tesamorelin, Ipamorelin. It allows researchers to examine these compounds together within one controlled experimental preparation and compare their complementary signalling pathways. Available strength: 6mg / 2mg. For laboratory research only; not for human consumption.
Research seriesCompound blend
A combined research formulation containing SS-31, MOTS-c. It allows researchers to examine these compounds together within one controlled experimental preparation and compare their complementary signalling pathways. Available strength: 10mg / 10mg. For laboratory research only; not for human consumption.
Research seriesCompound blend
A combined research formulation containing SS-31, MOTS-c, NAD+. It allows researchers to examine these compounds together within one controlled experimental preparation and compare their complementary signalling pathways. Available strength: 10mg / 10mg / 200mg. For laboratory research only; not for human consumption.
Research seriesCompound blend
A combined research formulation containing Glutathione, NMN, Resveratrol. It allows researchers to examine these compounds together within one controlled experimental preparation and compare their complementary signalling pathways. Available strength: 500mg / 500mg / 500mg. For laboratory research only; not for human consumption.
Research seriesCompound blend
A combined research formulation containing Glutathione, NAD+, Resveratrol. It allows researchers to examine these compounds together within one controlled experimental preparation and compare their complementary signalling pathways. Available strength: 500mg / 100mg / 500mg. For laboratory research only; not for human consumption.
